Department of Veterans Affairs Archives
Salt revs stomach bug’s cancer impact
May. 13, 2013—A high-salt diet worsens the carcinogenic effects of Helicobacter pylori, a bacterium that colonizes the stomachs of half of the world’s population.
Dual-action enzyme protects esophagus
May. 9, 2013—An antioxidant enzyme also functions as a tumor suppressor to limit cancer development in the esophagus.
Factor reduces virus-related asthma attacks
Apr. 26, 2013—An immune system factor associated with severe asthma may actually reduce asthma attacks induced by viral infections.
Lung damage protector
Apr. 12, 2013—Targeting repair pathways in the lung’s air sacs may be a valuable therapeutic direction for pulmonary fibrosis – the scarring of lung tissue.
Target for inflammatory bowel disease
Mar. 1, 2013—The factor STAT6 appears to play a role in the pathogenesis of an inflammatory bowel disease, suggesting it may be a promising target for new treatments.
Do-it-yourself repair in the kidney
Jan. 31, 2013—The kidney can mediate its own repair through proliferation of resident immune system cells.
Genetic clues to lung scarring
Dec. 10, 2012—A rare genetic syndrome provides new clues to lung scarring (pulmonary fibrosis), a potentially deadly consequence of many lung diseases.
More gene links to breast cancer risk
Oct. 19, 2012—Two newly identified gene variants linked to breast cancer may aid in predicting disease risk and targeting screening and prevention strategies.
Target acquired for aggressive tumor
Sep. 27, 2012—New therapeutic target for angiosarcoma – an aggressive, highly fatal tumor of the blood vessels – identified.
Targeting new pathways to ease pain
Aug. 30, 2012—The spinal cord’s neuropeptide Y signaling pathway may be a good target for new pain therapeutics.
Gene linked to familial prostate cancer
Aug. 23, 2012—A rare, inherited mutation confers an eightfold increased risk of prostate cancer, a recent study shows.
Long live the therapeutic stem cells
May. 17, 2012—Enhancing stem cell survival is key to improving cell-based therapies for regenerative medicine, and a new drug could help.
